大剂量生大黄辅助治疗重症急性胰腺炎肠麻痹的临床效果及C反应蛋白水平影响评价  

Clinical effects of large-dose raw rhubarb in adjuvant treatment on severe acute pancreatitis intestinal paralysis and C-reactive protein

作　　者：杨芳 Yang Fang

机构地区：[1]云南省楚雄彝族自治州中医医院,云南楚雄675000

出　　处：《中医临床研究》2021年第11期51-53,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:研究重症急性胰腺炎肠麻痹患者在采取大剂量生大黄辅助治疗时的影响。方法:2018年5月-2020年5月期间,选择51例重症急性胰腺炎肠麻痹患者作为试验组,采取大剂量生大黄辅助治疗;另外选择51例相同病例作为对照组,采取常规治疗,比较两组患者的治疗效果、不良反应发生率以及血液指标。结果:首先比较治疗效果,试验组的腹痛消退时间、肠胃功能恢复时间、住院时间、住院费用低于对照组,数据差异有统计学意义,P<0.05。其次比较不良反应发生率,数据差异有统计学意义,P<0.05。最后对比血液指标,试验组的白细胞、C反应蛋白、血淀粉酶水平与对照组相比差异有统计学意义,P<0.05。结论:对于重症急性胰腺炎肠麻痹患者而言,采取大剂量生大黄辅助治疗时疗效更优,另外不良反应发生率较低,有应用价值。Objective:To study the effect of large-dose rhubarb adjuvant therapy on patients with severe acute pancreatitis and enteroplegia.Methods:51 patients in the experimental group were treated with high-dose rhubarb as adjuvant treatment,51 identical cases were selected as the control group and conventional treatment was taken.Results:First of all.The time of abdominal pain subsidence,gastrointestinal function recovery time,hospitalization time,and hospitalization expenses in the experimental group were lower than the control groups,P<0.05.Secondly,there were statistically significonto differences in incidence of adverse reactions between groups,P<0.05.Finally,comparing the blood indicators,the levels of white blood cells,C-reactive protein,and blood amylase in the experimental group were better than the control group,P<0.05.Conclusion:For patients with severe acute pancreatitis and enteroparalysis,the effect of adjuvant treatment with large doses of raw rhubarb is better,and with lower incidence of adverse reactions,which has application value.

关 键 词：大剂量 生大黄 重症急性 胰腺炎 肠麻痹 

分 类 号：R256.3[医药卫生—中医内科学]